Finally, platinum can be used for HER2-negative advanced breast cancer that has failed treatment with anthracyclines and taxanes, including TNBC and hormone receptor (HR)-positive advanced breast cancer with visceral metastases and obvious clinical symptoms or resistance to endocrine therapy.[2,3]. The gene discussed is NR4A1; the disease is breast cancer.